ADAR1 Capital Management »

Structure Therapeutics shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Structure Therapeutics (GPCR) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Structure Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Structure Therapeutics held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Structure Therapeutics by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $141k 3.3k 42.86
2023-12-31 $163k 4.0k 40.76

More positions owned by ADAR1 Capital Management

Alnylam Pharmaceuticals (ALNY)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Roivant Sciences SHS (ROIV)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Protagonist Therapeutics (PTGX)
Cytokinetics Com New (CYTK)
Keros Therapeutics (KROS)
Royalty Pharma Shs Class A (RPRX)
Bridgebio Pharma (BBIO)
Merrimack Pharmaceuticals In Com New
Ascendis Pharma A/s Sponsored Adr (ASND)
Arbutus Biopharma (ABUS)
Avrobio Ord (AVRO)
Beigene Sponsored Adr (BGNE)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)

View all positions for ADAR1 Capital Management

Top funds holding Structure Therapeutics

Capital Research Global Investors
Henderson Group
Driehaus Capital Management
Federated Investors
BVF
T. Rowe Price Associates
RA Capital Management
Citadel Advisors
Logos Global Management
Capital Research and Management Company - Division 3
Point72 Asset Management
Octagon Capital Advisors
Vestal Point Capital
Rock Springs Capital Management
Deep Track Capital

View all funds holding Structure Therapeutics